UY SCUTI ACQUISITION CORP. ANNOUNCES CLOSING OF $50 MILLION INITIAL PUBLIC OFFERING
NEW YORK, April 2, 2025 /PRNewswire/ -- UY Scuti Acquisition Corp. (NASDAQ: UYSCU), (the "Company"), today announced the closing of its initial public offering of 5,000,000 units at an offering price of $10.00 per unit. Each unit consists of one...
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
MELBOURNE, Australia, April 2, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89Zr-olaratumab) in...
Seeing Machines Announces 3D Camera Technology for Next-Generation In-Cabin Monitoring Systems
Seeing Machines and Airy3D partner to supply the Automotive industry with low-impact, trustworthy 3D-vision for future in-cabin systems. CANBERRA, Australia, April 1, 2025 /PRNewswire/ -- Seeing Machines, the advanced computer vision technology...
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it...
Mega Matrix Inc. Filed 2024 Annual Report on Form 20-F
SINGAPORE, April 1, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), a short-video streaming platform and producer of short dramas, announces that it has filed its annual report on Form 20-F for the fiscal year...
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug...
Zeekr Group Announces March 2025 Delivery Update
HANGZHOU, China, April 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for March 2025. In...
Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season of the third BFC (Blokees Figures Creator) Creation Competition, themed "Breaking the Cocoon Season," was officially launched. This year's competition continues to adopt a...
Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research
Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered...
China Renaissance Announces 2024 Annual Results: Strong Recovery Driven by Strategic Transformation
HONG KONG, March 31, 2025 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Group", stock code: 1911.HK) today announced its annual results for the year ended December 31, 2024 (the "Reporting Period"). Despite a...